Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID07071987

A Multicenter, Randomized Controlled Trial to Evaluate the Efficacy of Thread Embedding Acupuncture in Reducing Postoperative Ileus After Colorectal Cancer Surgery

Led by Northern Jiangsu People's Hospital · Updated on 2025-07-18

300

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness and safety of thread embedding acupuncture (TEA) to help speed up gastrointestinal recovery after laparoscopic colorectal cancer surgery. This multicenter, randomized controlled trial focuses on patients with colorectal cancer, specifically assessing the time until first flatus as the primary outcome. Secondary outcomes include time to first bowel movement, ability to tolerate oral intake, length of hospital stay, and quality of life reported by patients. Participants are divided into three groups: one receiving thread embedding acupuncture combined with electroacupuncture, another receiving electroacupuncture alone, and a control group receiving standard care without acupuncture. Thread embedding acupuncture involves placing absorbable sutures under the skin at specific acupoints shortly after surgery, followed by electroacupuncture sessions at the same points over the next three days. All acupuncture procedures are performed by licensed professionals following strict protocols. During the study, participants will be monitored for gastrointestinal recovery progress through various assessments including time to first flatus and defecation, oral intake tolerance, and patient questionnaires on quality of life. The study also tracks hospital stay length and monitors for any complications. Participation spans the postoperative period up to 96 hours after surgery, with safety and recovery outcomes carefully recorded by the research team.

CONDITIONS

Brief Title

Effect of Thread Embedding Acupuncture on Postoperative Ileus Recovery After Colorectal Cancer Surgery: A Multicenter Randomized Controlled Trial

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 80 years
  • Diagnosed with stage I to III colorectal cancer
  • Scheduled for elective laparoscopic colorectal resection
  • ASA Physical Status I to III
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • History of prior major abdominal surgery
  • Emergency or palliative surgery
  • Combined organ resection or open conversion
  • Severe postoperative complications such as anastomotic leak or gastrointestinal bleeding
  • Severe cardiac, hepatic, renal, or psychiatric conditions
  • Refusal to undergo acupuncture

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery

Duration - Day of surgery

Participants undergo elective laparoscopic colorectal resection as part of their standard care.

1 visit (in-person)

Treatment

Duration - Up to 4 days post surgery

Participants receive thread embedding acupuncture and electroacupuncture or electroacupuncture alone at specified acupoints starting 2 hours after surgery and continuing at 24, 48, and 72 hours postoperatively.

4 visits (in-person) within 72 hours after surgery

Post-operative Follow-up

Duration - Up to 4 days after surgery

Participants are monitored for recovery outcomes including time to first flatus up to 96 hours after surgery.

Visits coinciding with treatment visits and assessments up to 96 hours

Trial Site Locations

Total: 1 location

1

Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, China, 225000

Actively Recruiting

Loading map...

Research Team

D

Daorong Wang, Doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Safety and Efficacy of 5-HT3 Receptor Antagonist Ramosetron ...

LARS - Low Anterior Resection Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here